77 related articles for article (PubMed ID: 33409868)
1. Newborn Screening for Severe Combined Immunodeficiency: 10-Year Experience at a Single Referral Center (2009-2018).
Thorsen J; Kolbert K; Joshi A; Baker M; Seroogy CM
J Clin Immunol; 2021 Apr; 41(3):595-602. PubMed ID: 33409868
[TBL] [Abstract][Full Text] [Related]
2. Implementing routine testing for severe combined immunodeficiency within Wisconsin's newborn screening program.
Baker MW; Laessig RH; Katcher ML; Routes JM; Grossman WJ; Verbsky J; Kurtycz DF; Brokopp CD
Public Health Rep; 2010; 125 Suppl 2(Suppl 2):88-95. PubMed ID: 20518449
[TBL] [Abstract][Full Text] [Related]
3. A Decade Experience on Severe Combined Immunodeficiency Phenotype in Oman, Bridging to Newborn Screening.
Al Sukaiti N; Ahmed K; Alshekaili J; Al Kindi M; Cook MC; Farsi TA
Front Immunol; 2020; 11():623199. PubMed ID: 33519828
[TBL] [Abstract][Full Text] [Related]
4. Reducing Mortality and Morbidity in Children with Severe Combined Immunodeficiency in Switzerland: the Role of Newborn Screening.
Soomann M; Prader S; Pinto Monteiro A; Zeilhofer U; Hauri-Hohl M; Güngör T; Pachlopnik Schmid J; Trück J; Felber M
J Clin Immunol; 2024 Jan; 44(1):39. PubMed ID: 38165471
[TBL] [Abstract][Full Text] [Related]
5. Fiscal implications of newborn screening in the diagnosis of severe combined immunodeficiency.
Kubiak C; Jyonouchi S; Kuo C; Garcia-Lloret M; Dorsey MJ; Sleasman J; Zbrozek AS; Perez EE
J Allergy Clin Immunol Pract; 2014; 2(6):697-702. PubMed ID: 25439359
[TBL] [Abstract][Full Text] [Related]
6. Impact of newborn screening for SCID on the management of congenital athymia.
Howley E; Golwala Z; Buckland M; Barzaghi F; Ghosh S; Hackett S; Hague R; Hauck F; Holzer U; Klocperk A; Koskenvuo M; Marcus N; Marzollo A; Pac M; Sinclair J; Speckmann C; Soomann M; Speirs L; Suresh S; Taque S; van Montfrans J; von Bernuth H; Wainstein BK; Worth A; Davies EG; Kreins AY
J Allergy Clin Immunol; 2024 Jan; 153(1):330-334. PubMed ID: 37678573
[TBL] [Abstract][Full Text] [Related]
7. A Cost-Effectiveness Analysis of Newborn Screening for Severe Combined Immunodeficiency in the UK.
Bessey A; Chilcott J; Leaviss J; de la Cruz C; Wong R
Int J Neonatal Screen; 2019 Sep; 5(3):28. PubMed ID: 33072987
[TBL] [Abstract][Full Text] [Related]
8. Utilization of next-generation sequencing to define the role of heterozygous
Pasternak Y; Vong L; Merico D; Abrego Fuentes L; Scott O; Sham M; Fraser M; Watts-Dickens A; Willett Pachul J; Kim VHD; Marshall CR; Scherer S; Roifman CM
J Allergy Clin Immunol Glob; 2024 Aug; 3(3):100267. PubMed ID: 38800615
[TBL] [Abstract][Full Text] [Related]
9. Parental Engagement in Identifying Information Needs After Newborn Screening for Families of Infants with Suspected Athymia.
Howley E; Soomann M; Kreins AY
J Clin Immunol; 2024 Mar; 44(3):79. PubMed ID: 38457046
[TBL] [Abstract][Full Text] [Related]
10. Using Long-Term Follow-Up Data to Classify Genetic Variants in Newborn Screened Conditions.
Wilhelm K; Edick MJ; Berry SA; Hartnett M; Brower A
Front Genet; 2022; 13():859837. PubMed ID: 35692825
[TBL] [Abstract][Full Text] [Related]
11. Actionability of commercial laboratory sequencing panels for newborn screening and the importance of transparency for parental decision-making.
DeCristo DM; Milko LV; O'Daniel JM; Foreman AKM; Mollison LF; Powell BC; Powell CM; Berg JS
Genome Med; 2021 Mar; 13(1):50. PubMed ID: 33781310
[TBL] [Abstract][Full Text] [Related]
12. Case Definitions for Conditions Identified by Newborn Screening Public Health Surveillance.
Sontag MK; Sarkar D; Comeau AM; Hassell K; Botto LD; Parad R; Rose SR; Wintergerst KA; Smith-Whitley K; Singh S; Yusuf C; Ojodu J; Copeland S; Hinton CF
Int J Neonatal Screen; 2018; 4(2):16. PubMed ID: 29862374
[TBL] [Abstract][Full Text] [Related]
13. Newborn Screening Today and Tomorrow: A Brief Report from the International Primary Immunodeficiencies Congress.
Solis L; Van Coillie S; Bonham JR; Hauck F; Hammarström L; Staal FJT; Lim B; Pergent M; Prévot J
Int J Neonatal Screen; 2024 Apr; 10(2):. PubMed ID: 38651395
[TBL] [Abstract][Full Text] [Related]
14. An Opportunity to Fill a Gap for Newborn Screening of Neurodevelopmental Disorders.
Chung WK; Kanne SM; Hu Z
Int J Neonatal Screen; 2024 Apr; 10(2):. PubMed ID: 38651398
[TBL] [Abstract][Full Text] [Related]
15. When Screening for Severe Combined Immunodeficiency (SCID) with T Cell Receptor Excision Circles Is Not SCID: a Case-Based Review.
Buchbinder D; Walter JE; Butte MJ; Chan WY; Chitty Lopez M; Dimitriades VR; Dorsey MJ; Nugent DJ; Puck JM; Singh J; Collins CA
J Clin Immunol; 2021 Feb; 41(2):294-302. PubMed ID: 33411155
[TBL] [Abstract][Full Text] [Related]
16. SCID newborn screening: What we've learned.
Currier R; Puck JM
J Allergy Clin Immunol; 2021 Feb; 147(2):417-426. PubMed ID: 33551023
[TBL] [Abstract][Full Text] [Related]
17. Methods and feasibility study for exome sequencing as a universal second-tier test in newborn screening.
Ruiz-Schultz N; Sant D; Norcross S; Dansithong W; Hart K; Asay B; Little J; Chung K; Oakeson KF; Young EL; Eilbeck K; Rohrwasser A
Genet Med; 2021 Apr; 23(4):767-776. PubMed ID: 33442025
[TBL] [Abstract][Full Text] [Related]
18. Clinical and Immunological Features of 96 Moroccan Children with SCID Phenotype: Two Decades' Experience.
Benhsaien I; Ailal F; El Bakkouri J; Jeddane L; Ouair H; Admou B; Bouskraoui M; Hbibi M; Hida M; Amenzoui N; Jouhadi Z; El Hafidi N; Rada N; Benajiba N; Abilkassem R; Badou A; Bousfiha AA
J Clin Immunol; 2021 Apr; 41(3):631-638. PubMed ID: 33411152
[TBL] [Abstract][Full Text] [Related]
19. Ten Years of Newborn Screening for Severe Combined Immunodeficiency (SCID) in Massachusetts.
Hale JE; Platt CD; Bonilla FA; Hay BN; Sullivan JL; Johnston AM; Pasternack MS; Hesterberg PE; Meissner HC; Cooper ER; Barmettler S; Farmer JR; Fisher D; Walter JE; Yang NJ; Sahai I; Eaton RB; DeMaria A; Notarangelo LD; Pai SY; Comeau AM
J Allergy Clin Immunol Pract; 2021 May; 9(5):2060-2067.e2. PubMed ID: 33607339
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
